EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of Quinazolone Pyridiniums as Potential Broad-Spectrum Antibacterial Agents

Jie Dai, Qianyue Li, Ziyi Li, Zhonglin Zang, Yan Luo, Chenghe Zhou iD

Molecules · 2025

DOI: 10.3390/molecules30020243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Jie Dai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Bioorganic & Medicinal Chemistry, Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engine…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Pyridinium Compounds, Quinazolinones, Drug Discovery. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China (NSFC), China, Key Project of Innovation Research 2035 Pilot Plan of Southwest University, China, National College Students' Innovation and Entrepreneurship Training Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The overprescription of antibiotics in medicine and agriculture has accelerated the development and spread of antibiotic resistance in bacteria, which severely limits the arsenal available to clinicians for treating bacterial infections. This work discovered a new class of heteroarylcyanovinyl quinazolones and quinazolone pyridiniums to surmount the increasingly severe bacterial resistance. Bioactive assays manifested that the highly active compound 19a exhibited strong inhibition against MRSA and Escherichia coli with extremely low MICs of 0.5 μg/mL, being eightfold more active than that of norfloxacin (MICs = 4 μg/mL). The highly active 19a with rapid bactericidal properties displayed imperceptible resistance development trends, negligible hemolytic toxicity, and effective biofilm inhibitory effects. Preliminary explorations on antibacterial mechanisms revealed that compound 19a could cause membrane damage, embed in intracellular DNA to hinder bacterial DNA replication, and induce metabolic dysfunction. Surprisingly, active 19a was found to trigger the conformational change in PBP2a of MRSA to open the active site, which might account for its high inhibition against MRSA. In addition, the little effect of molecule 19a on the production of reactive oxygen species indicated that bacterial death was not caused by oxidative stress. The above comprehensive analyses highlighted the large potential of quinazolone pyridiniums as multitargeting broad-spectrum antibacterial agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsPyridinium CompoundsQuinazolinonesDrug DiscoveryMicrobial Sensitivity TestsEscherichia coliMethicillin-Resistant Staphylococcus aureusBiofilmsHumansMolecular StructureStructure-Activity Relationship

Stichwörter der Autor:innen

PBP2aantibacterialpyridiniumquinazoloneresistance

Substanzen

Anti-Bacterial AgentsPyridinium CompoundsQuinazolinones

Autor:innen und Institutionen

  • Institute of Bioorganic & Medicinal Chemistry, Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, China.
  • College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators as Innovative Medicine, Chongqing University of Arts and Sci…

ORCID-Profile: Chenghe Zhou

Förderung

  • National Natural Science Foundation of China (NSFC), China
  • Key Project of Innovation Research 2035 Pilot Plan of Southwest University, China
  • National College Students' Innovation and Entrepreneurship Training Program
  • National Natural Science Foundation of China (NSFC)
  • Key Project of Innovation Research 2035 Pilot Plan of Southwest University
  • National College Students’ Innovation and Entrepreneurship Training Program

Zitieren

APA

Dai, J., Li, Q., Li, Z., Zang, Z., Luo, Y., & Zhou, C. (2025). Discovery of Quinazolone Pyridiniums as Potential Broad-Spectrum Antibacterial Agents. Molecules. https://doi.org/10.3390/molecules30020243

Vancouver

Dai J, Li Q, Li Z, Zang Z, Luo Y, Zhou C. Discovery of Quinazolone Pyridiniums as Potential Broad-Spectrum Antibacterial Agents. Molecules. 2025. doi:10.3390/molecules30020243

BibTeX
@article{Dai2025,
  author = {Dai, Jie and Li, Qianyue and Li, Ziyi and Zang, Zhonglin and Luo, Yan and Zhou, Chenghe},
  title = {Discovery of Quinazolone Pyridiniums as Potential Broad-Spectrum Antibacterial Agents},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30020243}
}
Kostenlos starten →